New hope for hemophilia a: phase 3 trial launches for Next-Gen bleed prevention
NCT ID NCT07416604
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new drug, NXT007, to an existing one (emicizumab) for preventing bleeding episodes in people aged 12 and older with hemophilia A. Participants may have severe, moderate, or mild disease, with or without factor VIII inhibitors. The goal is to see if NXT007 is more effective at reducing bleeds and improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Inherited Blood Disorders
RECRUITINGOrange, California, 92868, United States
-
Gunma University Hospital
RECRUITINGMaebashi, Gunma, 371-8511, Japan
-
Innovative Hematology, Inc.
RECRUITINGIndianapolis, Indiana, 46260, United States
-
Nagoya University Hospital
RECRUITINGNagoya, Aiti, 466-8560, Japan
-
Nara Medical University Hospital
RECRUITINGKashihara-shi, Nara, 634-8522, Japan
-
Ogikubo Hospital
RECRUITINGSuginami-Ku, Tokyo, 167-0035, Japan
-
The Chaim Sheba Medical Center - PPDS
RECRUITINGRamat Gan, Central District, 5262100, Israel
-
Washington Center for Bleeding Disorders
RECRUITINGSeattle, Washington, 98101-3932, United States